Related Experiment Video
Updated: May 14, 2026

12:20
Fabrication of Carbon Nanotube High-Frequency Nanoelectronic Biosensor for Sensing in High Ionic Strength Solutions
Published on: July 22, 2013
A Programmable Carbon Nanotube-Based Diagnostic Toolkit: Modular Architecture for Universal Multitarget Biosensing
Wanwei Qiu1, Lingmei Zhang1, Boshen Hao1
1School of Biomedicine and Health, Anhui Science and Technology University, Chuzhou 233100, China.
Analytical Chemistry
|May 13, 2026
Summary
This study introduces a versatile carbon nanotube (CNT)-based biosensor platform using modular antibody components. The programmable system enables rapid, adaptable diagnostics for various targets like tumor markers and mycotoxins.
Area of Science:
- Biosensor Engineering
- Materials Science
- Nanotechnology
Background:
- Traditional biosensors are often single-analyte specific, limiting their application scope.
- Developing universal diagnostic platforms requires overcoming limitations of single-analyte constraints.
- Modular architectures offer a promising approach for versatile biosensor development.
Purpose of the Study:
- To present a programmable carbon nanotube (CNT)-based lateral flow biosensor toolkit.
- To demonstrate a modular architecture enabling interchangeable antibody components for versatile diagnostics.
- To achieve significant signal amplification and superior colloidal stability for enhanced biosensing performance.
Main Methods:
- Utilized synergistic dual-treatment: HNO3/H2SO4 oxidation and Tween-20 surfactant modification of CNTs.
- Developed a modular design where antibodies are interchangeable molecular components.
- Applied the system to both sandwich immunoassays for tumor markers and competitive immunoassays for mycotoxins.
Main Results:
- Achieved 10-fold signal amplification and superior colloidal stability compared to conventional methods.
- Demonstrated successful application in detecting tumor markers (e.g., CEA, LOD 0.25 ng/mL) and mycotoxins (e.g., Ochratoxin A, LOD 4.31 pg/mL).
- Exhibited high performance in complex matrices: >95% specificity, <8% RSD, and 96-105% recovery.
Conclusions:
- The plug-and-play capability allows rapid analyte switching by only substituting antibodies.
- This modular approach minimizes development cycles, shifting focus from target-specific optimization to modular assembly.
- The platform offers a versatile framework for addressing diverse diagnostic challenges efficiently.

